HKU launches clinical trial in Hong Kong to treat chronic hepatitis B patients

Spread the love

The University of Hong Kong (HKU) has launched a clinical trial for a gene-related therapy aimed at treating chronic hepatitis B infection, giving patients hope for a cure in the future.
Professor Yuen Man-fung, chief of the division of gastroenterology and hepatology at HKU’s medical faculty, said on Thursday that existing medication for hepatitis B patients could only suppress the virus and had to be taken for decades.
He expected that the new treatment could enable patients to discontinue…

發佈留言

發佈留言必須填寫的電子郵件地址不會公開。 必填欄位標示為 *